One such model, the triple transgenic model (3xTg, knock-in of human PSEN1M146V, and transgenic expression of human APP with the Swedish mutation and human MAPTP301L), has been extensively used to study astrocyte pathology in AD (see Supplementary Table S2). The gene discussed is APP; the disease is Alzheimer disease.